Shares of Cipla on Tuesday rallied nearly 8 per cent in the mid-session trading a day after the company reported a 32.25 per cent rise in its profit to ₹1,068.41 crore in the third quarter.
The company's shares jumped 7.73 per cent to trade at ₹1,414 apiece on the BSE.
On the NSE, the scrip of Cipla climbed 7.47 per cent at 1,414.60 per piece.
In the mid-trading session on January 23, the 30-share BSE Sensex declined 708.90 points or 0.99 per cent lower trading at 70,714.75, while NSE Nifty slumped 1.05 per cent to trade at 21,344.40 points.
In a regulatory filing on January 22, pharmaceuticals firm Cipla Ltd reported a 32.25 per cent rise in consolidated profit to ₹1,068.41 crore in the third quarter ended December 2023.
The company had posted a consolidated profit of ₹807.83 crore in the year-ago period. Its consolidated revenue from operations in the quarter under review was ₹6,603.81 crore, up 13.66 per cent, the company said.
It was ₹5,810.09 crore in the corresponding period a year ago.
In the December quarter, its total expenses were 8.78 per cent higher at ₹5,119.81 crore as against ₹4,706.47 crore in the October-December quarter last fiscal.
Total income of Cipla in the third quarter stood at ₹6.788.44 crore, up 14.58 per cent. During the quarter, its revenue from pharmaceuticals was ₹6,365.06 crore, and from new ventures was ₹280.51 crore.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.